Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00722592
What this trial is testing

Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)

Who this might be right for
Ovarian Cancer
Endocyte 162
Testing effectiveness (Phase 2)Ended earlyNCT04579133
What this trial is testing

Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy

Who this might be right for
Bladder CancerUrothelial Carcinoma
Latin American Cooperative Oncology Group 140
Testing effectiveness (Phase 2)Study completedNCT06226350
What this trial is testing

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Who this might be right for
Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD 29
Early research (Phase 1)Study completedNCT05936138
What this trial is testing

A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.

Who this might be right for
Renal InsufficiencyHealthy
Eli Lilly and Company 24
Early research (Phase 1)Active Not RecruitingNCT04696731
What this trial is testing

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Allogene Therapeutics 120
Early research (Phase 1)Study completedNCT07165015
What this trial is testing

Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment

Who this might be right for
Renal ImpairmentHealthyRenal Insufficiency+1 more
Eli Lilly and Company 31
Early research (Phase 1)Study completedNCT02085538
What this trial is testing

Study Of Palbociclib (PD-0332991) In Renal Impairment

Who this might be right for
Renal Impairment
Pfizer 31
Early research (Phase 1)Study completedNCT01407276
What this trial is testing

Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)

Who this might be right for
Chronic Renal InsufficiencyType 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 49
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Not applicableStudy completedNCT01391351
What this trial is testing

Search for Predictors of Therapeutic Response in Ovarian Carcinoma

Who this might be right for
Carcinoma of the OvaryFallopian Tube CancerPeritoneal Serous-type Advanced Stage
Centre Francois Baclesse 107
Testing effectiveness (Phase 2)Study completedNCT05485896
What this trial is testing

Neoadjuvant Therapy of Pembrolizumab Plus Lenvatinib in Advanced RCC

Who this might be right for
Renal Cell Carcinoma
Tianjin Medical University Second Hospital 23
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Early research (Phase 1)Study completedNCT02299661
What this trial is testing

Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Renal DiseaseRenal Anemia
Daiichi Sankyo 31
Early research (Phase 1)Study completedNCT02399202
What this trial is testing

A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 15
Early research (Phase 1)Ended earlyNCT00303888
What this trial is testing

Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Yale University 31
Testing effectiveness (Phase 2)Looking for participantsNCT04519151
What this trial is testing

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsCarcinoma, Ovarian EpithelialNeoplasm of Stomach+5 more
Sheba Medical Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableStudy completedNCT00740454
What this trial is testing

Single Complete Compression Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy and Postpartum

Who this might be right for
Deep Vein Thrombosis
University Hospital, Brest 200
Large-scale testing (Phase 3)Study completedNCT02452866
What this trial is testing

Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219

Who this might be right for
Bacterial Vaginosis
Symbiomix Therapeutics 325
Testing effectiveness (Phase 2)Study completedNCT03735680
What this trial is testing

Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Who this might be right for
Breast CancerHead and Neck Squamous Cell CarcinomaColorectal Cancer+4 more
OncoNano Medicine, Inc. 30
Next Page